Schroder Investment Management Group Regeneron Pharmaceuticals, Inc. Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

A detailed history of Schroder Investment Management Group transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 95,001 shares of REGN stock, worth $63.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

95,001

Previous 73,897 28.56%

Holding current value

$63.9 Million

Previous $77.7 Million 28.58%

% of portfolio

0.11%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $21.6 Million - $25.4 Million	21,104 Added 28.56%	95,001 $99.9 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $6.6 Million - $8 Million	-7,469 Reduced 9.18%	73,897 $77.7 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $35.2 Million - $38.8 Million	39,022 Added 92.15%	81,366 $78.3 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $6.9 Million - $7.85 Million	8,901 Added 26.62%	42,344 $37.2 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $9.78 Million - $11.9 Million	-14,119 Reduced 29.69%	33,443 $27.5 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $65 Million - $77.1 Million	-92,897 Reduced 66.14%	47,562 $34.2 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $14.6 Million - $17.8 Million	-21,466 Reduced 13.26%	140,459 $115 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $10.4 Million - $11.2 Million	14,663 Added 9.96%	161,925 $117 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $50.6 Million - $63.8 Million	88,074 Added 148.8%	147,262 $101 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $5.04 Million - $6.79 Million	9,190 Added 18.38%	59,188 $35.4 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $12.6 Million - $14.8 Million	21,162 Added 73.39%	49,998 $34.6 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $8.86 Million - $10.9 Million	-16,298 Reduced 36.11%	28,836 $18.2 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $10.8 Million - $12.8 Million	18,823 Added 71.54%	45,134 $27.3 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $833,073 - $984,147	1,762 Added 7.18%	26,311 $14.7 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $738,891 - $906,722	-1,654 Reduced 6.31%	24,549 $11.6 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $1.41 Million - $1.8 Million	-2,956 Reduced 10.14%	26,203 $12.7 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $7.88 Million - $9.53 Million	14,473 Added 98.55%	29,159 $16.5 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $5.58 Million - $7.29 Million	11,320 Added 336.3%	14,686 $9.16 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $569,152 - $837,069	1,693 Added 101.2%	3,366 $1.7 Million
Q4 2019 Feb 11, 2020	SELL	$274.13 - $376.51 $1.25 Million - $1.71 Million	-4,551 Reduced 73.12%	1,673 $628,000
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $1.48 Million - $1.73 Million	5,419 Added 673.17%	6,224 $1.7 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $8,557 - $10,110	-23 Reduced 2.78%	805 $331,000
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $9,129 - $10,621	-26 Reduced 3.04%	828 $335,000
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $2.36 Million - $2.86 Million	-8,291 Reduced 90.66%	854 $292,000
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $1.26 Million - $1.57 Million	-3,993 Reduced 30.39%	9,145 $3.15 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $258,213 - $338,364	720 Added 5.8%	13,138 $4.94 Million
Q3 2017 Nov 09, 2017	BUY	$431.38 - $504.0 $5.36 Million - $6.26 Million	12,418	12,418 $5.4 Million

Others Institutions Holding REGN

# of Institutions

1,500

Shares Held

83M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Regeneron Pharmaceuticals, Inc. Transaction History